Clinical Trials Browser

Phase 1 × Breast Neoplasms × HM781-36B × Clear all

NCT03429101 2021-01-15

A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer

Phase 1 Terminated

Breast Neoplasms